webleads-tracker

US Sunshine Act

US Sunshine Act : The Open Payments user registration will begin February 18, 2014

On Fri, Feb 07, 2014 on the CMS Open Payments website, CMS made two major announcements:   The Open Payments user registration will begin February 18, 2014. Submission of “detailed” 2013 payment data will begin “in May” and will end no fewer than 30 days after it begins.  “Aggregated” payment data must still be submitted by the statutory deadline of March 31 Pour voir le détail de cette annonce  

Read More »

Pharma companies differ on Sunshine Act payment definition

There is still no consensus on whether medical writing or editorial services support from pharma companies should be reported under the Sunshine Act. That was one of the major take-home messages from last week’s European Meeting of the International Society for Medical Publications Professionals (ISMPP), which saw publication-focused representatives from Pfizer, AstraZeneca (AZ) and Shire discuss their take on the Sunshine Act. Pour lire l’article de PMLIVE

Read More »

Sunshine Act : Open Payments Mobile Apps for Physicians & Industry

The Centers for Medicare & Medicaid Services (CMS) developed two mobile apps to serve as tools that can be used by physicians, applicable manufacturers, and applicable Group Purchasing Organizations (GPOs) to track payments and other transfers of value made throughout the year. The mobile apps can be downloaded free of charge at the Google Play™ app store or iOS Apple™ app store, search for “OPEN PAYMENTS“, and used easily and conveniently on a mobile device. The mobile apps allow both industry and physician users to track payments and other transfers of value in real-time. One app is targeted specifically to …

Read More »

Conflits d’intérêts pharmaceutique-médecine : l’éducation plus efficace que la réglementation

Nous souhaitons d’une part mettre en perspective les relations entre les facultés de médecine et l’industrie pharmaceutique, et d’autre part, injecter un peu de raison dans le débat sur les conflits d’intérêts, lequel carbure aux dogmes que ceux-ci conduisent nécessairement à un biais qui déforme la vérité. Pour lire l’article paru dans Le Devoir

Read More »
X